JPC Survival Clause Samples
JPC Survival. Once GSK has elected to exercise the GSK Option, the JPC will continue solely as a forum to maintain information flow between GSK and SGI regarding the SGI Patents, and to discuss and agree on strategy in the event of an intellectual property dispute, e.g., an infringement action. All decisions made after exercise of the GSK Option with respect to the SGI Patents will be made at the sole discretion of GSK so long as such decisions otherwise comply and are consistent with the terms and conditions of this Agreement and do not impose any additional obligations, costs or expenses on SGI. For purposes of clarity, GSK’s reduction of royalty to SGI pursuant to Section 6(e) shall not be deemed additional obligations, costs or expenses on SGI.
JPC Survival. The JPC shall survive any expiration or termination of this Agreement (other than for breach) for a period of one (1) year from the date of such expiration or termination, which shall be extendable by the mutual written agreement of the Parties, in order to manage any affairs that may occur after such expiration or termination, such as review of any publication permitted under this Agreement.